1. Volume 8, Issue 3, Pages 219-225 (March 2007)
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial 
Prof Miguel Martín, Amparo Ruiz, MD, Monserrat Muñoz, MD, Ana Balil, MD, Jesús García-Mata, MD, Lourdes Calvo, MD, Eva Carrasco, MD, Esther Mahillo, PhD, Antonio Casado, MD, José Ángel García-Saenz, MD, M José Escudero, BSc, Vicente Guillem, MD, Carlos Jara, MD, Nuria Ribelles, MD, Fernando Salas, MD, Celia Soto, MD, Flavia Morales-Vasquez, MD, César A Rodríguez, MD, Encarna Adrover, MD, José Ramón Mel, MD 
The Lancet Oncology 
Volume 8, Issue 3, Pages (March 2007)
DOI: /S (07)
Copyright © 2007 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
*All patients who had signed a consent form were deemed as screened.
The Lancet Oncology 2007 8, DOI: ( /S (07) )
Copyright © 2007 Elsevier Ltd Terms and Conditions

3. Figure 2 Kaplan-Meier curves for progression-free survival
See Online for webtable
The Lancet Oncology 2007 8, DOI: ( /S (07) )
Copyright © 2007 Elsevier Ltd Terms and Conditions